Core Viewpoint - The company has completed the initial grant registration for its 2025 A-share stock option incentive plan, with a total of 24.7 million options granted at a price of 46.67 yuan per share [1] Group 1: Stock Option Plan Details - The registration date for the stock option incentive plan is November 14, 2025 [1] - A total of 226 individuals received the stock options, with 450,000 options being forfeited by 9 incentive recipients [1] - The maximum validity period for the incentive plan is 48 months, with the initial options divided into two exercise periods, each with a 50% exercise ratio [1] Group 2: Financial Implications - The total estimated expense to be amortized from 2025 to 2027 is 189.95 million yuan, broken down as follows: 33.79 million yuan in 2025, 115.09 million yuan in 2026, and 41.07 million yuan in 2027 [1]
君实生物:完成2470万份A股股票期权首次授予登记